Finance

Lists
Why is CING down 14.26%?
Dive Deeper
CING:NASDAQ
Cingulate Inc
$4.51
-14.26%
(-0.75) 1D
$4.61
+2.22% (+0.100)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CING...
Open
$5.20
High
$5.24
Low
$4.40
Mkt. cap
67.48M
Avg. vol.
230.33K
Volume
976.21K
52-wk high
$11.89
52-wk low
$3.16
EPS
-$2.86
Beta
-0.88
Shares outstanding
14.96M
No. of employees
14
Open
$5.20
High
$5.24
Low
$4.40
Mkt. cap
67.48M
Avg. vol.
230.33K
Volume
976.21K
52-wk high
$11.89
52-wk low
$3.16
EPS
-$2.86
Beta
-0.88
Shares outstanding
14.96M
No. of employees
14
News stories
From web sources and news partners
About Cingulate Inc
CEO-
Employees14
Founded2012
HeadquartersKansas City, Kansas, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 2 analysts giving stock ratings to CING in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CING in the last 3 months.
Highest
Current $4.51
$9.00 (+99.56%)
Average
$8.50 (+88.47%)
Lowest
$8.00 (+77.38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
$8.00
+77.4%
11/18/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$9.00
+99.6%
08/24/2026
Edward Woo
Ascendiant
Buy
Maintained
$44.00
+875.6%
08/19/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+343.5%
05/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
2.00M
2.18M
1.49M
-
Cost of revenue
2.00M
2.18M
1.49M
-
Research and development expenses
-
-
-
2.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.58M
5.74M
3.93M
4.58M
Operating expense
3.58M
5.74M
3.93M
7.49M
Total operating expenses
5.59M
7.92M
5.41M
7.49M
Operating income
-5.59M
-7.92M
-5.41M
-7.49M
Other non operating income
-133.99K
-852.03K
-314.01K
-69.32K
EBT including unusual items
-6.27M
-9.31M
-5.87M
-7.73M
EBT excluding unusual items
-6.27M
-9.31M
-5.87M
-7.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.27M
-9.31M
-5.87M
-7.73M
Net profit margin
-
-
-
-
Earnings per share
-0.84
-0.95
-0.45
-0.53
Interest and investment income
369.27K
-
-
-
Interest expense
-921.92K
-536.84K
-141.28K
-171.06K
Net interest expenses
-552.66K
-536.84K
-141.28K
-171.06K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.46M
-7.80M
-5.32M
-7.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps